ID

34385

Descripción

Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy; ODM derived from: https://clinicaltrials.gov/show/NCT00861172

Link

https://clinicaltrials.gov/show/NCT00861172

Palabras clave

  1. 17/1/19 17/1/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Lesions NCT00861172

Eligibility Lesions NCT00861172

  1. StudyEvent: Eligibility
    1. Eligibility Lesions NCT00861172
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age between 18 and 50 years.
Descripción

ID.1

Tipo de datos

boolean

health coverage.
Descripción

ID.2

Tipo de datos

boolean

any form of ms defined by mc donald's criteria (2005).
Descripción

ID.3

Tipo de datos

boolean

patients having shown an enhanced plaque on a less than six month mri examination.
Descripción

ID.4

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with an immunomodulating therapy like natalizumab (tysabri) and intravenous immunosuppressive therapies. other therapies will not be excluded from this study. for patients treated by systemic corticotherapy, a one-month delay will be necessary before a mri examination.
Descripción

ID.5

Tipo de datos

boolean

cerebral microangiopathy (diabetes, arterial hypertension, vascularitis…)
Descripción

ID.6

Tipo de datos

boolean

patient with classical mri contraindication like pace-maker, cardiac valvulosis, claustrophobia, allergy to contrast agent …
Descripción

ID.7

Tipo de datos

boolean

pregnancy or pregnancy desire.
Descripción

ID.8

Tipo de datos

boolean

patient with a low creatinine clearance <60 ml/mn
Descripción

ID.9

Tipo de datos

boolean

Similar models

Eligibility Lesions NCT00861172

  1. StudyEvent: Eligibility
    1. Eligibility Lesions NCT00861172
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age between 18 and 50 years.
boolean
ID.2
Item
health coverage.
boolean
ID.3
Item
any form of ms defined by mc donald's criteria (2005).
boolean
ID.4
Item
patients having shown an enhanced plaque on a less than six month mri examination.
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
patients with an immunomodulating therapy like natalizumab (tysabri) and intravenous immunosuppressive therapies. other therapies will not be excluded from this study. for patients treated by systemic corticotherapy, a one-month delay will be necessary before a mri examination.
boolean
ID.6
Item
cerebral microangiopathy (diabetes, arterial hypertension, vascularitis…)
boolean
ID.7
Item
patient with classical mri contraindication like pace-maker, cardiac valvulosis, claustrophobia, allergy to contrast agent …
boolean
ID.8
Item
pregnancy or pregnancy desire.
boolean
ID.9
Item
patient with a low creatinine clearance <60 ml/mn
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial